P
Peter J. Blankestijn
Researcher at Utrecht University
Publications - 290
Citations - 13171
Peter J. Blankestijn is an academic researcher from Utrecht University. The author has contributed to research in topics: Kidney disease & Blood pressure. The author has an hindex of 57, co-authored 277 publications receiving 11139 citations. Previous affiliations of Peter J. Blankestijn include Erasmus University Rotterdam.
Papers
More filters
Journal ArticleDOI
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
Brad C. Astor,Kunihiro Matsushita,Ron T. Gansevoort,Marije van der Velde,Mark Woodward,Andrew S. Levey,Paul E. de Jong,Josef Coresh,Meguid El-Nahas,Kai-Uwe Eckardt,Bertram L. Kasiske,Jackson T. Wright,Lawrence J. Appel,Tom Greene,Adeera Levin,Ognjenka Djurdjev,David C. Wheeler,Martin J Landray,John N. Townend,Jonathan Emberson,Laura E Clark,Alison M. MacLeod,Angharad Marks,Tariq Ali,Nicholas Fluck,Gordon Prescott,David H. Smith,Jessica R. Weinstein,Eric S. Johnson,Micah L. Thorp,Jack F.M. Wetzels,Peter J. Blankestijn,A D van Zuilen,Vandana Menon,Mark J. Sarnak,Gerald J. Beck,Florian Kronenberg,Barbara Kollerits,Marc Froissart,Bénédicte Stengel,Marie Metzger,Giuseppe Remuzzi,Piero Ruggenenti,Annalisa Perna,H. J. Lambers Heerspink,Barry M. Brenner,Dick de Zeeuw,Peter Rossing,Hans-Henrik Parving,Priscilla Auguste,Kasper Veldhuis,Yaping Wang,Laura Camarata,Beverly Thomas,Tom Manley +54 more
TL;DR: Lower eGFR and more severe albuminuria independently predict mortality and ESRD among individuals selected for CKD, with the associations stronger for E SRD than for mortality.
Journal ArticleDOI
Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
Gerry Ligtenberg,Peter J. Blankestijn,P. L. Oey,I. H. H. Klein,L.-T. Dijkhorst-Oei,F. Boomsma,G.H. Wieneke,A. C. van Huffelen,Hendrik A. Koomans +8 more
TL;DR: Increased sympathetic activity contributes to hypertension in patients with chronic renal disease and controls hypertension and decreases sympathetic hyperactivity.
Journal ArticleDOI
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi,Michel Azizi,Roland E. Schmieder,Felix Mahfoud,Felix Mahfoud,Michael A. Weber,Joost Daemen,Justin E. Davies,Jan Basile,Ajay J. Kirtane,Yale Wang,Melvin D. Lobo,Manish Saxena,Lida Feyz,Florian Rader,Philipp Lurz,Jeremy Sayer,Marc Sapoval,Marc Sapoval,Terry Levy,Kintur Sanghvi,Josephine Abraham,Andrew S.P. Sharp,Naomi D.L. Fisher,Michael J. Bloch,Helen Reeve-Stoffer,Leslie Coleman,Christopher M. Mullin,Laura Mauri,Laura Mauri,Desmond Jay,Nedaa Skeik,Robert S. Schwartz,Suhail Dohad,Ronald G. Victor,Josh Costello,Courtney Walsh,Theophilus Owan,Anu Abraham,Piotr Sobieszczky,Jonathan S. Williams,Chanwit Roongsritong,Thomas M. Todoran,Eric R. Powers,Emily Hodskins,Pete Fong,Cheryl L. Laffer,James Gainer,Mark Robbins,John P. Reilly,Michael Cash,Jessie Goldman,Sandeep Aggarwal,Gary Ledley,David H. Hsi,Scott Martin,Edward Portnay,David A. Calhoun,Thomas McElderry,William Maddox,Suzanne Oparil,Pei-Hsiu Huang,Powell Jose,Matheen Khuddus,Suzanne Zentko,James O'Meara,Ilie Barb,Joseph Garasic,Doug Drachman,Randy Zusman,Kenneth Rosenfield,Chandan Devireddy,Janice P. Lea,Bryan Wells,Rick Stouffer,Alan L. Hinderliter,Eric Pauley,Srinivasa Potluri,Scott Biedermann,Sripal Bangalore,Stephen Williams,David A. Zidar,Mehdi H. Shishehbor,Barry Effron,Marco Costa,Jai Radhakrishnan,Anthony Mathur,Ajay Jain,Sudha Ganesh Iyer,Nicholas M Robinson,Sadat Ali Edroos,Amit N. Patel,David Beckett,Clare Bent,Neil Chapman,Matthew J. Shun-Shin,James P. Howard,Anil Joseph,Richard D'Souza,Robert Gerber,Mohamad Faris,Andrew J. Marshall,Cristina Elorz,Robert Höllriegel,Karl Fengler,Karl-Philipp Rommel,Michael Böhm,Sebastian Ewen,Jelena Lucic,Christian Ott,Axel Schmid,Michael Uder,L. Christian Rump,Johannes Stegbauer,Patric Kröpil,Erika Cornu,David Fouassier,Philippe Gosse,Antoine Cremer,Hervé Trillaud,Panteleimon Papadopoulos,Atul Pathak,Benjamin Honton,Pierre Lantelme,Constance Berge,Pierre-Yves Courand,Peter J. Blankestijn,Michiel Voskuil,Zwaantina Rittersma,A. A. Kroon,W. H. Van Zwam,Alexandre Persu,Jean Renkin +132 more
TL;DR: In this article, the authors investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.
Journal ArticleDOI
Effect of Online Hemodiafiltration on All-Cause Mortality and Cardiovascular Outcomes
Muriel P.C. Grooteman,Marinus A. van den Dorpel,Michiel L. Bots,E. Lars Penne,Neelke C. van der Weerd,Albert H.A. Mazairac,Claire H. den Hoedt,Ingeborg van der Tweel,Renée Lévesque,Menso J. Nubé,Piet M. ter Wee,Peter J. Blankestijn +11 more
TL;DR: This trial did not detect a beneficial effect of hemodiafiltration on all-cause mortality and cardiovascular events compared with low-flux hemodialysis, but on-treatment analysis suggests the possibility of a survival benefit among patients who receive high-volume hemodiiltration, although this subgroup finding requires confirmation.
Journal ArticleDOI
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension
Bakhtawar K. Mahmoodi,Kunihiro Matsushita,Mark Woodward,Peter J. Blankestijn,Massimo Cirillo,Takayoshi Ohkubo,Peter Rossing,Mark J. Sarnak,Bénédicte Stengel,Kazumasa Yamagishi,Kentaro Yamashita,Luxia Zhang,Josef Coresh,de Paul Jong,Brad C. Astor,Chronic Kidney Dis Prognosis Conso +15 more
TL;DR: Chronic kidney disease should be regarded as at least an equally relevant risk factor for mortality and ESRD in individuals without hypertension as it is in those with hypertension.